Pharmacology Flashcards
7 cards from real FISDAP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Pharmacology flashcards as text
A patient in pulseless VT does not respond to defibrillation. Which antiarrhythmic is given first per ACLS?
Answer: Amiodarone 300 mg IV push
Amiodarone 300 mg IV push is the first-line antiarrhythmic for shock-refractory VF/pulseless VT in the ACLS algorithm.
Which route of administration provides the fastest onset of action in a conscious patient with hypoglycemia who is unable to swallow?
Answer: Intramuscular glucagon
IM glucagon is rapidly absorbed and stimulates hepatic glycogenolysis, making it appropriate when IV access is unavailable and the patient cannot swallow safely.
A patient with known asthma is wheezing. Albuterol works primarily by activating which receptor type?
Answer: Beta-2 adrenergic
Albuterol is a selective beta-2 agonist that causes bronchial smooth muscle relaxation and bronchodilation.
What is the primary indication for magnesium sulfate administration in the prehospital setting?
Answer: Torsades de pointes and eclampsia
Magnesium sulfate is first-line treatment for torsades de pointes and is used to prevent eclamptic seizures in preeclampsia.
Which medication should be avoided in a patient with suspected epiglottitis who is maintaining their airway?
Answer: Anything that may agitate the patient
Any intervention that agitates the patient with epiglottitis risks complete airway obstruction; the priority is calm, gentle transport to definitive care.
Morphine's analgesic properties are primarily due to its agonist activity at which receptor?
Answer: Mu opioid receptor
Morphine's primary analgesic, euphoric, and respiratory depressant effects occur through agonism at mu (μ) opioid receptors.
Which statement about the pharmacokinetics of sublingual nitroglycerin is correct?
Answer: It is rapidly absorbed through sublingual mucosa, bypassing first-pass metabolism
Sublingual nitroglycerin is absorbed directly into systemic circulation through the sublingual mucosa, avoiding first-pass hepatic degradation and achieving rapid onset.